The recent demonstration of a role of E. coli in the development of invasive carcinoma in mice ushers a new era of bacterial involvement in cancer etiology. It has been shown previously that the colonic mucosa of colorectal carcinoma (CRC) is exclusively colonized by intracellular E. coli instead of extracellular form found in normal colonic mucosa. Surprisingly, the DNA repair gene MUTYH, which is a homologue of the E. coli gene mutY, is responsible for CRC. The current paper discusses the potential role of mutY in CRC etiology and concludes that research in this area can bring together the diverse threads of the CRC etiology puzzle.
Introduction
The enigmatic relationship of E. coli with colorectal cancer (CRC) has always raised suspicions for cancer researchers in the role of this bacterium in cancer development.
Recently, an article published in the August 2012 issue of Science revealed that E. coli has the capability to promote invasive carcinoma in mice [1] . Although verification of its etiological potential in humans is still awaiting a legitimate appraisal, a logical mechanistic explanation for this association has been provided through chronic inflammation. Induction of proinflammatory cytokines and highly reactive chemical species during chronic inflammation leads to oxidation, nitration and chlorination of DNA, RNA and proteins. [2] .
Khan et al suggested that the frequent association of E. coli with CRC may allow the bacteria to serve as an indicator of cancer development [3] . E. coli infection is involved in chronic inflammation of the intestine during inflammatory bowel disease (IBD). It has been observed that the pathogenesis of IBD involves a consistent increase in mucosa-associated E. coli with an "adherent and invasive" phenotype. Although many other bacterial species are also involved in IBD [4] , the recent demonstration of E. coli induced carcinogenesis in mice attracts our attention towards this organism as a possible CRC etiologic agent in humans.
Two forms of IBD, including Crohn's disease (CD) and ulcerative colitis (UC), are associated with an increased risk in the development of colon cancer [5, 6] .
E. coli: a host cell cycle modulator
Several studies have considered the potential role of microbes in CRC etiology [7, 8] . A role for E. coli in CRC etiology gained much interest after finding mounting evidence for this association [9] . It has been verified in many studies that E. coli has an enormous potential for cell cycle modulation, thus increasing the chances for the development of cancer. Some E. coli strains produce cyclomodulins which interfere with the host cell cycle and may serve as a possible link for the association with E. coli and CRC [10] . In addition, cytotoxic necrotizing factor (CNF) is a cyclomodulin produced by E. coli; CNF activates rho GTP binding protein and prevents apoptosis. CNF modulates both mitochondrial homeostasis and the expression of Bcl-2 member of apoptotic regulators. It acts as an apoptosis inhibitor and cell cycle stimulator due to the induction of DNA replication and G1/S transition [11] [12] [13] . Another E. coli cyclomodulin, known as cycle inhibiting factor (Cif), has the ability to cause irreversible arrest of the cell cycle at the G2/M transition [14] . Cif, which is produced by enteropathogenic (EPEC) and enterohaemorrhagic (EHEC) E. coli strains [15] , activates G2/M arrest by activating a DNA damage independent pathway through sustained inhibitory phosphorylation of mitosis inducer CDK1 [14] . Cif also causes unique alterations in the actin cytoskeleton leading to its anchoring to the host cell membrane and cellular and nuclear enlargement. Nuclear enlargement occurs due to continuous DNA replication in the absence of nuclear division [16] . This endoreduplication increases cellular DNA content and also increases gene copy number and proteins including growth factors leading to rapid growth of cells and possibly cancer [13, 17, 18] . Moreover, E. coli also produces cytolethal distending toxin (CDT), which causes cell cycle arrest by inflicting DNA damage [19, 20] . CDT is a tripartite complex with the CdtB subunit homologous to human DNAse I [21] . The role of CDT in the carcinogenic process has been investigated in a microbial induced hepatocarcinogenesis mouse model. In this model it was observed that Helicobacter hepaticus CDT promoted the development of dysplasia from hepatitis and increased proliferation of hepatocytes [22] .
It has been reported recently that host cell mismatch repair activity of E. coli infected cells is reduced in colon cancer cell lines as well as CRC patients [23] . A reduction of DNA repair activity is directly related to an accumulation of mutations and is a suspected reason for E. coli driven cancer. Besides these attributes of cell metabolism in E. coli induced cancer etiology, this bacteria have little or no capacity for the conversion of N-hydroxy-4-acetylaminobiphenyl (N-OH-AABP) to 4-acetylaminobiphenyl, which reverses activation of the parent carcinogen in the gut [24] . It has been known for some time that the gut microflora have the capacity to convert several carcinogens to harmless products in the intestine and thus minimize the cancer risk [25] . However, during IBD E. coli is generally present as a prominent organism and can reduce this attribute of the gut microflora. Although many pieces of evidence support a proposed carcinogenic activity of E. coli, a satisfactory consensus cannot be achieved on any single mechanism. This situation demands the detection of firm evidence and the identification of specific mechanism for the E. coli-CRC association.
E. coli and CRC: a peculiar association
In addition to the mechanistic link between chronic inflammation and CRC development, it is also worthy of note that the colorectal carcinoma mucosa, but not normal colonic mucosa, is colonised by intracellular E. coli [26] . Chronic inflammation and consequent tissue damage induces a cascade of pro-inflammatory and anti-inflammatory molecules. The equilibrium between these two groups of regulators controls cell death and repair of tissue damage caused due to cell death. However, any problems with this equilibrium may lead to the development of cancer [27] . Cellular mutations are additional factors in regulating the development of CRC. Several cellular mutations have been identified as etiologic factors for colon cancer and these have been reviewed in many recent articles [28] . Among the mutations linked to CRC, MUTYH, which encodes for DNA glycosylase, is one of a number of genes involved in regulating oxidative DNA damage repair [29] . Although germ line mutations in MUTYH are linked to hereditary CRC, somatic mutations in this gene are also associated with cases of CRC [30] . It is noteworthy that the cellular MUTYH gene is a homologue of the E. coli gene mutY, which is also responsible for regulating DNA damage repair [29] . Thus it offers an additional target for investigating the E. coli-CRC association.
Possible role for the involvement of mutY in CRC etiology
Considering the diverse lines of evidence described above for the microbial etiology of CRC, it is interesting to consider a potential role for the E. coli mutY gene in the development of colon cancer. E. coli can exist as a chronic intracellular pathogen in colon cells and this intimate association between the bacteria and colon cells provides an opportunity for the bacteria to grow for many generations and for the old bacterial cells to release their contents into the colon cell cytoplasm. Thus, we can speculate that the intracellular E. coli will release their DNA and mutY gene products into the colon cell.
This hypothesis raises three interesting questions. 
Direct effects of mutY protein or its epigenetic regulators and CRC
Due to the high degree of homology between the bacterial mutY and eukaryotic MUTYH genes, both functional and structural analogies between the gene products are likely. It has been observed previously that the same enzymes from different organisms can differ in their degree of substrate specificity. This phenomenon is evident even for equivalent enzymes isolated from different bacteria. In the case of the equivalent enzyme from humans and E.
coli, which are evolutionary distant, it is reasonable to propose that the presence of both enzymes in the same cell at one time can interfere with each other's activity. This latter scenario raises the possibility that DNA repair can be impaired, allowing the accumulation of mutations that ultimately lead to CRC. As discussed earlier, E. coli has the ability to reduce host cell DNA mismatch repair (MMR) in colonic cell lines and this has also been observed in CRC patients. This process has been suggested as a possible mechanism for E. coli induced colon carcinogenesis [23] . Enteropathogenic E. coli (EPEC) has been shown to secrete an effector protein (EspF), which is responsible for the reduction of MMR proteins [34] . However, the role of mutY in reducing the DNA repair activity of E. coli infected eukaryotic cells also requires a detailed appraisal.
It is relevant to note that microbes posses the ability to carry out epigenetic alterations of their host eukaryotic cells and induce pathological changes through epigenetic reprogramming proteins from the cytoplasm to nucleus, although proteins with molecular weights < 40 kDa can transfer to the nucleus via a passive transport mechanism [45, 46] . Surprisingly, the mutY protein (NCBI Accession number EGT70329) has a molecular weight of 39.18 kDa giving strong support for its nuclear localization via the passive transport mechanism. Similar to the possible mutY nuclear transport, the epigenetic regulators have a high propensity for an intracellular localization due to functional relatedness. For example, E. coli replication terminator protein Tus, an E. coli epigenetic regulator, has both a NLS and nuclear export signal (NES), and can therefore target the host cell nucleus. Although research in this area is in the early days, Tus protein was one of the first proteins shown to possess both NLS and NES, thus supporting a role in epigenetic targeting of the host cell nucleus [47] . However, future research on bacterial epigenetic regulators will, no doubt, identify similar host nuclear targeting potential for many E. coli proteins, perhaps including mutY. Therefore, chronic E.
coli infection may create a situation where chronic inflammation, caused by the E. coli infection, leads to mutY mediated cellular alterations in the host cell DNA repair machinery that controls the development of CRC.
Concluding remarks
Our current understanding of CRC pathogenesis raises suspicion for a potential role of E. coli mutY in colon cancer and research in this direction is uncovering several aspects of CRC pathogenesis. Further research is required to address the potential role of E. coli in colon cancer development. Several aspects of the proposal outlined above, specifically the intracellular growth of E. coli in colon cancer cells, the homology between the mutY and MUTYH genes, possible horizontal gene transfer from the intracellular E. coli during colon cancer, and the presence of mutY and MUTYH gene products in same cell provide clues for linking these threads. Further research will provide new avenues to understand CRC etiology and help us to plan and implement infection control measures to control CRC. Managing an infection is much easier than managing the cancer itself; hence the role of E. coli mutY in CRC should be investigated further.
